Recently, Larry Jones, Global Vice President and Group Chief Information Officer of Medical Technology at Johnson&Johnson (NYSE: JNJ), will leave the world's second-largest medical device manufacturer. He will retire from Johnson&Johnson's medical device business. The details of when and when the official resignation will take place, or who will take over, are still unknown.

01. Retirement of Group Chief Information Officer
Recently, Larry Jones announced that he will retire from Johnson&Johnson's medical device business. When asked when he will officially resign or if someone will replace him, he said he will share more details when the information becomes public. Johnson&Johnson Medical Technology did not respond to further information requests.

Jones is a goal oriented leader who achieves transformational change through key principles such as business process integration, agile methods, and next-generation technology solutions. He focuses on driving digital surgical connectivity solutions for Johnson&Johnson's oncology, orthopedics, cardiovascular, and general surgery robots and machine learning platforms. He served as the cross regional global Chief Information Officer at Janssen Pharmaceuticals for over 6 years. He is an executive member of the Johnson&Johnson African American Leadership Council and the Johnson&Johnson Regional Leadership Council for Diversity and Inclusion, as well as a member of Microsoft and Verizon's Healthcare Industry Advisory Board. In 2019, Jones won the award of ITSMF and Harlem Fine Arts Association for his lifelong achievements in the field of technology. He was also nominated as InspireCIO's 2019 New York/New Jersey CIO of the Year.

Jones holds a Master's degree in Computer Engineering/Business Administration from the University of Pennsylvania and the Wharton School. He also obtained a Bachelor's degree in Computer Science from St. Peter's University.

After spending an incredible 35 years at Johnson&Johnson, I am starting to look back on the extraordinary journey we have taken together, "Jones said on LinkedIn

For friends and partners along the way, this is not a farewell - it's just a 'meet again', "he later added, stating that he was about to embark on" an exciting new chapter in his life and career journey ".

Our dedication to patients, communities, customers, and employees has always inspired me, and I am immensely proud of our achievements, "Jones wrote in a LinkedIn post. Our success proves that the global teams and leaders I have worked with are outstanding, creating a family like atmosphere that makes every challenge worthwhile... I bring countless precious memories, stories, and experiences. Thank you very much to everyone

I would like to sincerely thank my family for their unwavering support, and especially thank my wife - my coach, whose love and encouragement are invaluable to me, "he continued. I also want to thank my father, he is a great and humble role model. He has cultivated in me a firm and resilient work attitude

As I embark on this exciting new chapter in my life and career journey, I remain committed to utilizing technology to benefit humanity, promote global health equity, and combat chronic diseases, "Jones concluded.

On the LinkedIn page, Jones stated that his recent achievements include "completing a three-year, $200 million global digital transformation plan to drive lean business processes, cloud based solutions, and comprehensive insights.

02. There have been many personnel changes within a year
Johnson&Johnson Medical Technology has undergone significant personnel changes in the past year.

Just one year ago this month, Ashley McEvoy announced her surprising resignation from her position as Global Chair of Johnson&Johnson Medical Technology. She continued to serve as a consultant until February 2024, after which Tim Schmid took over as the head of the medical device business.

In August of this year, Peter Fasolo, Executive Vice President and Chief Human Resources Officer who has been working at Johnson&Johnson for nearly 20 years, plans to retire at the end of this year. Peter Fasolo has been working at Johnson&Johnson for nearly 20 years and plans to retire at the end of this year. The company has chosen Kristen Mulholland to replace him, effective from October 1st. Fasuolo and Muholland will collaborate during a transitional period until Fasuolo officially retires.

In addition, Johnson&Johnson China also has multiple personnel changes:
In August of this year, Kevin Chen, General Manager and Head of External Affairs and Market Access of Johnson&Johnson's Cardiovascular and Professional Solutions Division in China, submitted his resignation to the company and sought opportunities for external development. He worked at Johnson&Johnson until September 16, 2024. During the transition phase, Edward Zhou will temporarily take over the management of the Cardiovascular and Professional Solutions Division, as well as the External Affairs and Market Access Department. Chen Chuhui joined Johnson&Johnson in 2009 and has held management positions in the ASP business unit, Endo business unit, ultrasonic knife business unit, as well as the Gynecologe and Manto business units. After returning to Johnson&Johnson in 2015, he also served as an important leader in channel management, strategic customer, operations, and professional education.

In July, Johnson&Johnson announced that Edward Zhou will assume the position of President of Johnson&Johnson Medical Technology China from July 25, 2024, and will also become a member of Johnson&Johnson Medical Technology's Asia Pacific leadership team. Zhou Mintao has nearly 30 years of work experience at Johnson&Johnson. He joined Johnson&Johnson's consumer goods business as a sales representative in 1992 and later served as the general manager of Johnson&Johnson's consumer goods business in Singapore. After returning to China, he served as the General Manager of Johnson&Johnson's Consumer Products Business in China. In 2015, he served as the Vice President of the Surgical Business Department of the Care Health Division, and in 2016, he became the General Manager of the Care Health Division in China.

In April, Johnson&Johnson announced the departure of Song Weiqun, Chairman of the China region and President of Johnson&Johnson Medical Technology China. In 2003, Song Weiqun joined Johnson&Johnson as the only global management trainee at the company's headquarters in the United States. Will Song has only worked for one company to date: Johnson&Johnson. Johnson&Johnson's first locally born Chinese regional chairman.

In April, Johnson&Johnson announced that Ronnie Chen would serve as the head of human resources for Johnson&Johnson Medical Technology China&OneHR China. Chen Yanli is the former vice president of talent and organizational culture in China of Roche Pharmaceuticals and the head of the Key Account Management Department of China Market Access Hospital.

At the end of March, Johnson&Johnson Medical Technology announced the appointment of Tulio Oliveira as the new General Manager of its Surgical Division in China. Prior to joining the Chinese team, Tulio served as the Global Head of Advanced Staplement Surgery at Johnson&Johnson Medical Technology. Tulio joined Johnson&Johnson in 2003 as a sales representative for the Brazilian market, working in Brazil, the United States, Chile, and Argentina. His responsibilities span across sales, marketing, new business development, global strategic marketing, strategic planning, and comprehensive management.

Source: http://qixieke.com/Font/index/detailPage.html?id=3242-23